Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | AMPH | TSHA | ||
| Company | Supernus Pharm | Amphastar Pharma | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 26.49 | 38.57 | 2.30 | ||
| High | 26.49 | 38.57 | 2.31 | ||
| Low | 25.66 | 37.30 | 2.14 | ||
| Last | 25.77 | 37.58 | 2.16 | ||
| Change | -0.78 | -0.93 | -0.10 | ||
| % Change | -2.94% | -2.41% | -4.42% | ||
| Volume | 271,000 | 599,800 | 2,035,900 | ||
| 20-Day Average Volume | 761,470 | 388,515 | 4,599,800 | ||
| Previous Close | 26.55 | 38.51 | 2.26 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.67 | 40.45 | 3.20 | ||
| 20-Day Raw Stochastic | 8.54% | 4.52% | 13.25% | ||
| 20-Day Relative Strength | 38.08% | 32.90% | 38.56% | ||
| Weighted Alpha | -16.03 | -35.99 | -0.73 | ||
| Today's Opinion | 88% Sell | 100% Sell | 8% Buy | ||
| Previous Opinion | 88% Sell | 100% Sell | 8% Buy | ||
| Last Month's Opinion | 40% Sell | 56% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.79% since 06/25/24 | -7.39% since 06/25/24 | -12.37% since 06/25/24 | ||
| Low | 25.66 on 07/02/24 | 37.30 on 07/02/24 | 1.83 on 06/26/24 | ||
| High | 27.55 on 06/28/24 | 41.48 on 06/27/24 | 2.40 on 07/01/24 | ||
| 1-Month | |||||
| %Chg | -4.98% since 05/31/24 | -11.22% since 05/31/24 | -37.03% since 05/31/24 | ||
| Low | 25.53 on 06/14/24 | 37.30 on 07/02/24 | 1.83 on 06/26/24 | ||
| High | 28.34 on 06/04/24 | 43.49 on 06/04/24 | 4.32 on 06/13/24 | ||
| 3-Month | |||||
| %Chg | -22.31% since 04/02/24 | -11.20% since 04/02/24 | -20.30% since 04/02/24 | ||
| Low | 25.53 on 06/14/24 | 37.30 on 07/02/24 | 1.83 on 06/26/24 | ||
| High | 34.49 on 04/04/24 | 46.62 on 05/09/24 | 4.32 on 06/13/24 | ||
| 6-Month | |||||
| %Chg | -7.07% since 01/02/24 | -39.67% since 01/02/24 | +26.32% since 01/02/24 | ||
| Low | 25.53 on 06/14/24 | 37.30 on 07/02/24 | 1.38 on 01/19/24 | ||
| High | 35.44 on 03/21/24 | 65.92 on 01/05/24 | 4.32 on 06/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,416,680 | 1,837,737 | 403,959 | ||
| Shares Outstanding, K | 54,974 | 48,902 | 187,018 | ||
| Annual Sales | 607,520,000 | 644,400,000 | 15,450,000 | ||
| Annual Net Income | 1,320,000 | 137,550,000 | -111,570,000 | ||
| Last Quarter Sales | 143,640,000 | 171,840,000 | 3,410,000 | ||
| Last Quarter Net Income | 120,000 | 43,180,000 | -24,060,000 | ||
| 60-Month Beta | 0.91 | 0.80 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 05/08/24 | 1.04 on 05/08/24 | -0.10 on 05/14/24 | ||
| Latest Earnings Date | 08/13/24 | 08/13/24 | 08/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.33 | 0.00 | ||